Private Capital Group’s Ionis Pharmaceuticals IONS Stock Holding History

Private Capital Group’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-31	Closed	-$1K	–	2152
2021 Q4	$1K	Hold	31	–	–	﹤0.01%	1945
2021 Q3	$1K	Hold	31	–	–	﹤0.01%	2004
2021 Q2	$1K	Hold	31	–	–	﹤0.01%	1972
2021 Q1	$1K	Hold	31	–	–	﹤0.01%	1881
2020 Q4	$2K	Hold	31	–	–	﹤0.01%	1780
2020 Q3	$1K	Hold	31	–	–	﹤0.01%	1853
2020 Q2	$2K	Hold	31	–	–	﹤0.01%	1694
2020 Q1	$1K	Hold	31	–	–	﹤0.01%	1808
2019 Q4	$1K	Hold	31	–	–	﹤0.01%	1804
2019 Q3	$2K	Hold	31	–	–	﹤0.01%	1900
2019 Q2	$1K	Hold	31	–	–	﹤0.01%	2039
2019 Q1	$3K	Hold	31	–	–	﹤0.01%	1807
2018 Q4	$2K	Hold	31	–	–	﹤0.01%	1877
2018 Q3	$1K	Hold	31	–	–	﹤0.01%	2070
2018 Q2	$1K	Sell	31 -20	-39%	-$887	﹤0.01%	2019
2018 Q1	$2K	Hold	51	–	–	﹤0.01%	1847
2017 Q4	$3K	Buy	+51	New	+$2.8K	﹤0.01%	1761

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

Private Capital Group's IONS Position: Q1 2022 in Review

Private Capital Group sold out of Ionis Pharmaceuticals (IONS) in Q1 2022, closing a stake of 31 shares — an estimated $1K sold.

Private Capital Group first reported a position in IONS in Q4 2017 and held it in 17 quarters. The position peaked at $3K in Q1 2019. 334 funds tracked by Wall St. Rank hold IONS as of Q1 2022.

Private Capital Group reported no remaining Ionis Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Private Capital Group sold 31 Ionis Pharmaceuticals shares in Q1 2022, an estimated $1K.
Private Capital Group first reported a position in Ionis Pharmaceuticals in Q4 2017 and held it in 17 quarters.
Private Capital Group's Ionis Pharmaceuticals position peaked at $3K in Q1 2019.
334 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2022.

Based on Private Capital Group's 13F filing for Q1 2022, filed 21 Apr 2022.